Conditions: Endometrial Endometrioid Adenocarcinoma; Stage I Uterine Corpus Cancer AJCC v8; Stage IA Uterine Corpus Cancer AJCC v8; Stage IB Uterine Corpus Cancer AJCC v8; Stage II Uterine Corpus Cancer AJCC v8
Interventions: Radiation: Brachytherapy; Radiation: External Beam Radiation Therapy; Biological: Pembrolizumab; Other: Quality-of-Life Assessment; Other: Questionnaire Administration
Sponsors: National Cancer Institute (NCI); NRG Oncology
**RECRUITING NOW**
Interventions: Radiation: Brachytherapy; Radiation: External Beam Radiation Therapy; Biological: Pembrolizumab; Other: Quality-of-Life Assessment; Other: Questionnaire Administration
Sponsors: National Cancer Institute (NCI); NRG Oncology
**RECRUITING NOW**
Source: View full study details on ClinicalTrials.gov
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
